Price target upside
Vertex Pharmaceuticals Price Target Upside or Downside
VRTX price target upside based on the current price and analyst average.
Direct answer
Vertex Pharmaceuticals's analyst target implies +17.5%.
The average target is $557.13 compared with a recorded current price of $474.26.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 3, 2026.
Verified data
- Current price
- $474.26
- Average price target
- $557.13
- High price target
- $652.00
- Low price target
- $350.00
- Target upside
- +17.5%
- Consensus rating
- Buy
- Analysts
- 24
- Evidence date
- August 3, 2026
- Valid through
- August 10, 2026